Pollen Clinical Trials

• Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-Adsorbed Allergoid Preparation of Birch Pollen Allergens
  ClinicalTrials.gov Identifier: NCT00263627 - Active, not recruiting
  Pollen Allergy
  
• Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00309036 - Active, not recruiting
  Grass Pollen Allergy
  
• Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
  ClinicalTrials.gov Identifier: NCT00264459 - Active, not recruiting
  Grass Pollen Allergy
  
• Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV
  ClinicalTrials.gov Identifier: NCT00266526 - Active, not recruiting
  Birch Pollen Allergy
  
• Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00309062 - Active, not recruiting
  Birch Pollen Allergy
  
• Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00263601 - Active, not recruiting
  Grass Pollen Allergy
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen
  ClinicalTrials.gov Identifier: NCT00241410 - Active, not recruiting
  Type I Hypersensitivity
  
• The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit
  ClinicalTrials.gov Identifier: NCT00209365 - Completed
  Asthma,; Seasonal Allergic Rhinitis
  
• Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen
  ClinicalTrials.gov Identifier: NCT00518518 - Active, not recruiting
  Asthma
  
• Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
  ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
  Allergy
  
• Influence of Nutrition on Nosal and Bronchial Affliction in Patients With Allery on Grass-Pollen
  ClinicalTrials.gov Identifier: NCT00519740 - Active, not recruiting
  Bronchial Hyperreactivity; Hypersensitivity; Allergy; Bronchial Asthma
  
• Safety and Repeatability of Brochial Challenge With Grass-Pollen
  ClinicalTrials.gov Identifier: NCT00507039 - Recruiting
  Allergic Asthma
  
• Lactobacillus Acidophilus L92 on Markers of Allergic Inflammation by Nasal Provocation With Grass Pollen
  ClinicalTrials.gov Identifier: NCT00554736 - Recruiting
  Hayfever
  
• Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
  Allergy
  
• Efficacy-Safety Study of Sublingual Immunoth. With Depigmented-Polymerized Pollen Extracts to Treat Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00550875 - Recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid with Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
  ClinicalTrials.gov Identifier: NCT00133159 - Completed
  Type I Hypersensitivity
  
• Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid with Monophosphoryl Lipid a (MPL) in Patients Sensitized to Tree Pollen
  ClinicalTrials.gov Identifier: NCT00118612 - Completed
  Type I Hypersensitivity
  
• Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma
  ClinicalTrials.gov Identifier: NCT00135642 - Completed
  Seasonal Allergic Rhinoconjunctivitis
  
• Sublingual Immunotherapy in Adults with Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00146965 - Completed
  Seasonal Allergic Rhinoconjunctivitis
  
• Subcutaneous Immunotherapy in Patients with Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00146939 - Completed
  Seasonal Allergic Rhinoconjunctivitis
  
• Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy
  ClinicalTrials.gov Identifier: NCT00293904 - Completed
  Hypersensitivity
  
• A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy
  ClinicalTrials.gov Identifier: NCT00470457 - Completed
  Rhinoconjunctivitis Due to Grass Pollen Allergy
  
• Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
  ClinicalTrials.gov Identifier: NCT00377728 - Completed
  Seasonal Allergic Rhinitis
  
• Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
  ClinicalTrials.gov Identifier: NCT00521040 - Completed
  Rhinitis, Allergic, Seasonal
  
• Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
  ClinicalTrials.gov Identifier: NCT00291642 - Completed
  Rhinitis, Allergic, Seasonal
  
• Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
  ClinicalTrials.gov Identifier: NCT00315523 - Completed
  Rhinitis, Allergic, Seasonal
  
• Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)(COMPLETED)
  ClinicalTrials.gov Identifier: NCT00423995 - Completed
  Seasonal Allergic Rhinitis
  
• One Tablet Sublingual Immunotherapy in Adults with Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00146991 - Terminated
  Seasonal Allergic Rhinoconjunctivitis
  
• Study to Assess the Clinical Efficacy and Safety of a Novel Method of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects by Epicutanous Allergen Administration
  ClinicalTrials.gov Identifier: NCT00457444 - Completed
  Rhinoconjunctivitis
  
• Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber
  ClinicalTrials.gov Identifier: NCT00430157 - Completed
  Seasonal Allergic Rhinitis
  
• Induction of Immunogenicity with Different Doses of TreeMATA in Subjects Allergic to Tree Pollen
  ClinicalTrials.gov Identifier: NCT00113750 - Completed
  Type I Hypersensitivity
  
• Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid using Skin Prick Testing
  ClinicalTrials.gov Identifier: NCT00104390 - Completed
  Type I Hypersensitivity
  
• Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid using Skin Prick Testing
  ClinicalTrials.gov Identifier: NCT00107705 - Completed
  Type I Hypersensitivity
  
• Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen
  ClinicalTrials.gov Identifier: NCT00426179 - Completed
  Seasonal Allergic Rhinitis
  
• Assessment of Residual Allergenicity of Ragweed Pollen Allergoid with Monophosphoryl Lipid A (MPL) Using Skin Prick Testing
  ClinicalTrials.gov Identifier: NCT00116285 - Completed
  Type I Hypersensitivity
  
• Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
  ClinicalTrials.gov Identifier: NCT00133146 - Completed
  Type I Hypersensitivity
  
• Induction of Immunogenicity with Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen
  ClinicalTrials.gov Identifier: NCT00104377 - Completed
  Type I Hypersensitivity
  
• Prevention of Asthma with Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering from Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)
  ClinicalTrials.gov Identifier: NCT00152464 - Completed
  Dermatitis, Atopic
  
• Prevention of Asthma with Levocetirizine (36 Month Treatment) in Young Children Suffering from Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial
  ClinicalTrials.gov Identifier: NCT00160563 - Completed
  Prevention of asthma
  
• Assessment of the Contribution of Monophosphoryl Lipid a (MPL) to a Tree Pollen Allergy Vaccine
  ClinicalTrials.gov Identifier: NCT00118625 - Completed
  Type I Hypersensitivity
  
• Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients
  ClinicalTrials.gov Identifier: NCT00410930 - Terminated
  Allergy
  
• Evaluation of Safety and Tolerability of Tyrosine Adsorbed Ragweed Pollen Allergoid with MPL (Monophosphoryl Lipid A)
  ClinicalTrials.gov Identifier: NCT00109759 - Suspended
  Type I Hypersensitivity
  
• Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis
  ClinicalTrials.gov Identifier: NCT00367640 - Terminated
  Allergy
  
• Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan
  ClinicalTrials.gov Identifier: NCT00276445 - Terminated
  Allergic Conjunctivitis